Thu, Jan 2, 7:11 PM (46 days ago)
**Summary of Financial Performance for Dogecoin Cash, Inc. (CBDS) - Q3 2024** For the third quarter ended September 30, 2024, Dogecoin Cash, Inc. reported a revenue decline of 27% to $189,121 compared to $271,207 in Q3 2023. The decrease is attributed to heightened competition in the cannabis telemedicine sector. Gross profit also fell by 26% to $118,872, with a gross margin of 63%. Total operating expenses decreased by 41% to $300,719, primarily due to reductions in wages, salaries, and professional fees, leading to a net loss from continuing operations of $181,847, an 18% improvement from a loss of $221,524 in the prior year. For the nine months ended September 30, 2024, revenue decreased by 31% to $648,643, with a net loss of $554,583. Cash flow from operating activities was negative at $78,400, with cash on hand at $41,352. The company's accumulated deficit reached $82,895,826. The report includes an amendment to correct omissions regarding share issuances. The company plans to raise capital to address liquidity challenges, which may lead to shareholder dilution. The strategic shift towards cryptocurrency integration is noted, following the name change from Cannabis Sativa, Inc. to Dogecoin Cash, Inc. Future operations may be impacted by ongoing market uncertainties and competitive pressures.